22
02, 2016

Medgold identifies a new 3km zone of mineralization at Valongo

22 Feb, 2016

Vancouver, Canada, February 22, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce that recent exploration of a new prospect called Guimarei on the Valongo licence in northern Portugal, has identified anomalous gold in rocks outcropping over a 3 km strike length. Assay results from rock chip sampling range from trace gold to highlights of 7.80 g/t Au, 4.84 g/t Au and 2.53 g/t Au. Dan James, President of Medgold, said: “Guimarei is a brand new gold discovery by Medgold. We’ve picked up gold mineralization[…]

20
01, 2016

Medgold Applies for Mineral Concessions in Serbia

20 Jan, 2016

Vancouver, Canada, January 20, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce it has established a wholly-owned subsidiary in the Republic of Serbia, and has subsequently applied for a 100 sq. km exploration licence targeting newly identified epithermal-porphyry mineralization in the country. Dan James, the President of Medgold, said: “We’re excited to establish ourselves in Serbia which has a long and rich history and culture of mining. The country has a tremendous metal endowment and Serbia’s mining industry enjoys high-level government support. Our decision[…]

12
01, 2016

Medgold to extend warrants, and issues shares for services

12 Jan, 2016

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada, January 12, 2016;¬†Medgold Resources Corp. (TSX-V: MED) announces that management has determined that it is in the best interests of the Company to extend the expiry date of certain previously issued private placement warrants. Accordingly, subject to TSX Venture Exchange acceptance, the Company intends to extend the expiry date of outstanding warrants to purchase up to 9,550,000 common shares at $0.15 per share by one year to February 4, 2017, and outstanding warrants[…]

11
01, 2016

Medgold Expands Joint Venture with Centerra

11 Jan, 2016

Vancouver, Canada, January 11, 2016;¬†Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce that Medgold has expanded its joint venture with Centerra Gold Inc. (“Centerra”) to include its Boticas and Chaves gold exploration licences. The two licences will be added to the existing joint-venture agreement currently covering the Valongo Belt licences. Dan James, President of Medgold, said: “We are very pleased to announce that we’ve amended our joint venture agreement with Centerra to include the Boticas and Chaves licences in Portugal. We’ve enjoyed a good working[…]